Figure 1From: Cellular immunotherapy for refractory hematological malignancies Schematic depicting key time points for blood sample accrual for translational studies to be incorporated into the Cellular Therapy Protocol (HLA= Human leukocyte antigen, KIR= Killer-cell immunoglobulin-like receptor, STR= short tandem repeat, CRS= Cyokine release syndrome). Back to article page